Literature DB >> 11916556

Radiobiological characteristics of solid tumours depending on the p53 status of the tumour cells, with emphasis on the response of intratumour quiescent cells.

S Masunaga1, K Ono, A Takahashi, T Ohnishi, Y Kinashi, M Takagaki.   

Abstract

Human head and neck squamous cell carcinoma cells transfected with mutant TP53 (SAS/mTP53) or with a neo vector as a control (SAS/neo) were inoculated subcutaneously (s.c.) into both hind legs of Balb/cA nude mice. Mice bearing tumours received 5-bromo-2'-deoxyuridine (BrdU) continuously to label all proliferating (P) cells in the tumours. The mice then received gamma-ray irradiation. Another group of mice received a series of test doses of gamma-rays while alive or after tumour clamping to obtain hypoxic fractions (HFs) in the tumours. Right after irradiation, the tumour cells were isolated and incubated with a cytokinesis blocker. The micronucleus (MN) frequency in the cells without BrdU labelling (=quiescent (Q) cells) was determined using immunofluorescence staining for BrdU. Meanwhile, 6 h after irradiation, tumour cell suspensions obtained in the same manner were used for determining the frequency of apoptosis in the Q cells. The MN frequency and apoptosis frequency in total (P+Q) tumour cells were determined from the tumours that were not pretreated with BrdU. In total cell populations, SAS/mTP53 cells were more radioresistant than SAS/neo cells in clonogenic survival. Q tumour cells exhibited a significantly lower apoptosis and MN frequency, probably due to their much larger HF, than total cells. In both total and Q cell fractions, SAS/mTP53 cells were less susceptible to apoptosis and more susceptible to micronucleation than SAS/neo cells. Obviously, TP53 status had the potential to influence the radiosensitivity of not only the total cells, but also the Q cells. However, irrespective of the TP53 status, significant differences in radiosensitivity between total and Q tumour cells were consistently observed. From the viewpoint of tumour control as a whole, including intratumour Q tumour cell control, a treatment modality for enhancing the Q cell response has to be considered.

Entities:  

Mesh:

Year:  2002        PMID: 11916556     DOI: 10.1016/s0959-8049(01)00430-0

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  10 in total

1.  UNC5H4-induced apoptosis in non-small cell lung cancer is not dependent on p53 status only.

Authors:  Zhong-Hai Zhao; LE Lin; A Liang; Hong-Qiu Li; Yue Zhu
Journal:  Oncol Lett       Date:  2013-09-09       Impact factor: 2.967

2.  Impact of the p53 status of the tumor cells on the effect of reactor neutron beam irradiation, with emphasis on the response of intratumor quiescent cells.

Authors:  Shin-ichiro Masunaga; Koji Ono; Akihisa Takahashi; Yoshinori Sakurai; Ken Ohnishi; Toru Kobayashi; Yuko Kinashi; Masao Takagaki; Takeo Ohnishi
Journal:  Jpn J Cancer Res       Date:  2002-12

3.  Radiosensitivity and Capacity to Recover from Radiation-Induced Damage in Pimonidazole-Unlabeled Intratumor Quiescent Cells Depend on p53 Status.

Authors:  Shin-Ichiro Masunaga; Yong Liu; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Natsuko Kondo; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2011-02-26

4.  Effects of p53 Status of Tumor Cells and Combined Treatment With Mild Hyperthermia, Wortmannin or Caffeine on Recovery From Radiation-Induced Damage.

Authors:  Shin-Ichiro Masunaga; Keizo Tano; Yu Sanada; Minoru Suzuki; Akihisa Takahashi; Ken Ohnishi; Koji Ono
Journal:  World J Oncol       Date:  2019-06-29

5.  An attempt to improve the therapeutic effect of boron neutron capture therapy using commonly employed 10B-carriers based on analytical studies on the correlation among quiescent tumor cell characteristics, tumor heterogeneity and cancer stemness.

Authors:  Shin-Ichiro Masunaga; Yu Sanada; Keizo Tano; Yoshinori Sakurai; Hiroki Tanaka; Takushi Takata; Minoru Suzuki; Koji Ono
Journal:  J Radiat Res       Date:  2020-11-16       Impact factor: 2.724

6.  Wortmannin efficiently suppresses the recovery from radiation-induced damage in pimonidazole-unlabeled quiescent tumor cell population.

Authors:  Shin-Ichiro Masunaga; Yoshinori Sakurai; Hiroki Tanaka; Minoru Suzuki; Natsuko Kondo; Masaru Narabayashi; Akira Maruhashi; Koji Ono
Journal:  J Radiat Res       Date:  2012-10-24       Impact factor: 2.724

7.  Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour.

Authors:  G Driessens; L Harsan; B Robaye; D Waroquier; P Browaeys; X Giannakopoulos; T Velu; C Bruyns
Journal:  Br J Cancer       Date:  2003-08-18       Impact factor: 7.640

8.  The Effect of p53 Status of Tumor Cells on Radiosensitivity of Irradiated Tumors With Carbon-Ion Beams Compared With γ-Rays or Reactor Neutron Beams.

Authors:  Shin-Ichiro Masunaga; Akiko Uzawa; Ryoichi Hirayama; Yoshitaka Matsumoto; Yoshinori Sakurai; Hiroki Tanaka; Keizo Tano; Yu Sanada; Minoru Suzuki; Akira Maruhashi; Koji Ono
Journal:  World J Oncol       Date:  2015-08-27

9.  The Effect of p53 Status on Radio-Sensitivity of Quiescent Tumor Cell Population Irradiated With γ-Rays at Various Dose Rates.

Authors:  Shin-Ichiro Masunaga; Junya Kobayashi; Keizo Tano; Yu Sanada; Minoru Suzuki; Koji Ono
Journal:  J Clin Med Res       Date:  2018-10-09

Review 10.  Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family Members.

Authors:  Atsushi Kaida; Tomoo Iwakuma
Journal:  Int J Mol Sci       Date:  2021-12-16       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.